Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 6 hours agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Insider Sale at Laboratory Corp of America Holdings (LH)
Guru Focus· 18 minutes agoLaboratory Corp of America Holdings (LH, Financial) operates as a leading global life sciences company that provides vital information to help doctors, hospitals,
California is joining with a New Jersey company to buy a generic opioid overdose reversal drug
The Hill· 3 days agoCalifornia is partnering with a New Jersey-based pharmaceutical company to purchase a generic...
Mark Cuban Cost Plus Drug Company to Supply ScionHealth Utilizing Safecor Health Program
WKBN 27 Youngstown· 13 hours agoThe company's Cost Plus Drugs...
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 hour agoInvestment in R&D and commercialization efforts underline NBIX's commitment to innovation....
Deciphera acquisition by ONO Pharmaceutical at $2.4 billion By Investing.com
Investing.com· 10 hours agoDeciphera Pharmaceuticals , Inc. (NASDAQ: NASDAQ:DCPH), a biopharmaceutical company specializing in...
Healthcare and drugmaker groups seek to revive challenge to US drug-pricing law
Reuters· 8 hours agoHealthcare and drug industry groups on Wednesday urged a U.S. appeals court to revive their...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
NBC Washington· 1 day agoFederal regulators are challenging patents on 20 brand name drugs, including the blockbuster...
Chinese companies lead ADC pipeline
Pharmaceutical Technology via Yahoo Finance· 14 hours agoAntibody drug conjugates (ADCs) are a rapidly growing therapeutic class that leading data and analytics company GlobalData forecasts will generate more...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 8 hours agoWhile this was 20% below its first-quarter 2023 revenue, it wasn't unexpected -- the company continues to see a notable fall-off in sales of its Covid...